Pertussis trend in children under one year of age in the Czech Republic in 1997–2013
Authors:
K. Fabiánová 1,3; H. Šebestová 2; Č. Beneš 2; J. Zavadilová 1; P. Křížová 1; B. Kříž 1,3
Authors‘ workplace:
Centrum epidemiologie a mikrobiologie, Státní zdravotní ústav, Praha
1; Oddělení biostatistiky a informatiky, Státní zdravotní ústav, Praha
2; Ústav epidemiologie, 3. LF UK, Praha
3
Published in:
Epidemiol. Mikrobiol. Imunol. 63, 2014, č. 4, s. 270-277
Category:
Review articles, original papers, case report
Overview
Study objective:
To characterize the epidemiological situa-tion of pertussis in children under one year of age in the Czech Republic in 1997–2013.
Material and methods:
The study cohort consisted of children under one year of age with laboratory confirmed pertussis reported to the communicable disease system from 1997 to 2013. A total of 265 pertussis cases were reported in children under one year of age over the study period. Selected demographic data, need for hospitalization, and vaccination history were evaluated in the study cohort.
Results:
Children under one year of age have shown a steady upward trend in reported cases of pertussis since the 1990s. The reported incidence of pertussis in this age group was the lowest in 1998 (1.1/100 000 population) and the highest in 2013 (31.3/100 000). In 1997–2013, 265 pertussis cases were reported in children under one year of age, 128 females and 137 males, to the communicable disease system in the Czech Republic. Most of these children, nearly 77 %, developed pertussis within the first four months of life. Of the 265 children, 79 % were not vaccinated before the onset of the disease and 21 % were immunized with at least one dose of pertussis vaccine before developing the disease. As many as 75 % of the children with pertussis needed hospitalization. Most of them, nearly 81 %, were hospitalized with pertussis in the first four months of life and 90 % of them in the first six months of life.
Conclusions:
In 1997 – 2013, an upward trend was observed in pertussis cases in children under one year of age. Most children developed the disease within the first four months of life while not vaccinated against pertussis. This fact unambiguously supports the „cocoon“ strategy, i.e. vaccination of the closest contacts of the child, and a booster dose at 25 years of age. At the same time, a question arises whether to provide vaccination to pregnant women.
Key words:
pertussis in children under one year of age – incidence – mortality – hospitalization – vaccination
Sources
1. Cherry JD. Epidemic pertussis in 2012 – the resurgence of a vaccine-preventable disease. N Engl J Med, 2012;367(9):785–787.
2. Mattoo S, Chery JD. Molecular pathogenesis, epidemiology, and clinical manifestations of respirátory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Mikrobiol Rev, 2005;18(2):326–382.
3. Bisgard KM, Pascual FB, Ehresmann KR, Miller CA, et al. Infant pertussis: who was the source? Pediatr Infect Dis J, 2004;23(11):985–89.
4. Wendelboe AM, Njamkepo E, Bourillon A, Floret DD, et al. Transmission of Bordetella pertussis to young infants. Pediatr Infect Dis J, 2007;26(4):293–299.
5. WHO. Revised guidance on the choice of pertussis vaccines: July 2014. Wkly Epidemiol Rec, 2014; 89(30):337–344 [online]. [cit. 2014-07-30] Dostupný na www:
http://www.who.int/wer/2014/wer8930/en/. ISSN 0049-8114.
6. Baptista PN, Magalhaes VS, Rodrigues LC. The role of adults in household outbreaks of pertussis. Int J Infect Dis, 2010;14(2):e111–114.
7. Frumkin K. Pertussis and persistent cough: practical, clinical and epidemiologic issues. The Journal of emergency medicine, 2013;44(4):889–895.
8. CDC. 2012 Final Pertussis Surveillance Report. [online] [cit. 2014-08-08] Dostupný na www:
http://www.cdc.gov/pertussis/surv-reporting.html
9. CDC. 2013 Provisional Pertussis Surveillance Report. [online] [cit. 2014-08-08] Dostupný na www:
www.cdc.gov/pertussis/-surveillance-report.pdf.
10. Haberling DL, Holman RC, Paddock CD, Murphy TV. Infant and maternal risk factors for pertussis-related infant mortality in the United States, 1999 to 2004. Pediatr Infect Dis J, 2009;28:194–198.
11. Vitek CR, Pascual FB, Baughman AL, Murphy TV. Increase in deaths from pertussis among young infants in the United States in the 1990s. Pediatr Infect Dis J, 2003;22:628–634.
12. Winter K, Harriman K, Zipprich J, Schechter R, et al. California pertussis epidemic, 2010. J Pediatr, 2012;161:1091–1096.
13. Paddock CD, Sanden GN, Cherry JD, Gal AA, et al. Pathology and pathogenesis of fatal Bordetella pertussis infection in infants. Clin Infect Dis, 2008;47(3):328–338.
14. Van Hoek AJ, Campbell H, Amirthalingam G, Andrews N, et al. The number of deaths among infants under one year of age in England with pertussis: results of a capture/recapture analysis for the period 2001 to 2011. Eurosurveillance, 2013;18(9).
15. Swamy GK, Wheeler SM. Neonatal pertussis, cocooning and maternal immunization. Expert Rev Vaccines, 2014;1–8.
16. WHO. Pertussis vaccines: WHO position paper. Wkly Epidemiol Rec, 2010;85(40):385–400.
17. Gustafsson L, Hessel L, Storsaeter J, Olin P. Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of age. Pediatrics, 2006;118;978–984.
18. WHO [online] [cit. 2014-08-08] Dostupný na www: http://apps.who.int/immunization_monitoring/globalsummary/coverages?c=CZE
19. Centers for Disease Control and Prevention. Atlanta. Pertussis (Whooping cough). [online]. [cit. 2014-08-10] Dostupný na www: http://www.cdc.gov/pertussis/clinical/complications.html
20. Fabiánová K. Pertuse a současné možnosti očkování. Vakcinologie, 2011;5(3):116-126.
21. Pertussis report 2011-04-13. California Department of Public Health, 2011 [cit. 2012-07-30] Dostupný na www: http://www.cdph.ca.gov/programs/immunize/Documents/PertussisReport2011-04-13.pdf
22. Swamy GK, Wheeler SM. Neonatal pertussis, cocooning and maternal immunization. Expert Rev Vaccines, 2014;1–8.
23. Esposito S, Bosis S, Morlacchi L, Baggi E, et al. Can infants be protected by means of maternal vaccination? Clin Microbiol Infect, 2012;18(Suppl 5):85–92.
24. Castagnini LA, Healy CM, Rench MA, Wootton SH, et al. Impact of maternal postpartum tetanus and diphtheria toxoids and acellular pertussis immunization on infant pertussis infection. CID, 2012;54(1):78–84.
25. Vysoká–Buriánová B. Pertuse – Parapertuse. Disertační práce. 1961, Praha.
26. Bechini A, Tiscione E, Boccalini S, Levi M, et al. Acellular pertussis vaccine use in risk groups (adolescents, pregnant women, newborns and health care workers): A review of evidences and recommendations. Vaccine, 2012;30(35):5179–190.
27. Gall SA, Myers J, Pichichero M. Maternal immunization with tetanus-diphtheria-pertussis vaccine: effect on maternal and neonatal serum antibody levels. American Journal of Obstetrics and Gynecology, 2011;204:334.e1–5.
Labels
Hygiene and epidemiology Medical virology Clinical microbiologyArticle was published in
Epidemiology, Microbiology, Immunology
2014 Issue 4
Most read in this issue
- Prevalence study of nosocomial infections in university hospitals in the Czech Republic
- Seroprevalence of Anaplasma phagocytophilum in patients with suspected Lyme borreliosis
- Current situation in clinical trials with vaccines in the Czech Republic
-
Infections caused by non-Typhi serovars of Salmonella at the
Infectious Diseases Clinic of the University Hospital Brno in 2011–2013